Table 2 Lymphoepithelioma-like carcinoma of the urinary bladder: clinical and pathological results in 93 cases
From: Lymphoepithelioma-like carcinoma of the urinary bladder: a case report and review of the literature
Features | Patient population | |
|---|---|---|
Sex | (n = 65) | |
Male | 48 (74%) | |
Female | 17 (26%) | |
Age | (n = 62) | |
Mean | 70.0 | |
Range | 52-90 | |
Chief complaint | (n = 35) | |
GH | 31 (88%) | |
GH and Urgency | 3 (9%) | |
GH and Miction pain | 1 (3%) | |
Histology | (n = 90) | |
Pure | 39 (43%) | |
Predominant | 26 (29%) | |
Focal | 13 (15%) | |
Mixed | 12 (13%) | |
Pathological stage (T) | (n = 92) | |
T1 | 14 (15%) | |
T2 | 52 (56%) | |
T3 | 24 (27%) | |
T4 | 2 (2%) | |
Primary treatment | (n = 92) | |
TURBT | 51 (55%) | |
Partial cystectomy | 6 (7%) | |
Radical cystectomy | 35 (38%) | |
Adjuvant treatment | (n = 92) | |
Systemic chemotherapy | 21 (23%) | |
Radiotherapy | 14 (15%) | |
Chemoradiotherapy | 6 (7%) | |
Intravesical chemotherapy | 3 (3%) | |
Not performed | 48 (52%) | |
Follow-up | (n = 87) | |
Mean | 30.4 (months) | |
Range | 0-216 (months) | |
Outcome | (n = 87) | |
Not evidence of disease (NED) | 59 (67%) | |
Died of disease (DOD) | 14 (17%) | |
Died without disease (DWD) | 9 (10%) | |
Alive with metastases (AWM) | 5 (6%) | |
Cause-specific survival rate | 83% |